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Abstract
Background: Vitiligo is an acquired hypomelanosis that affects bet-
ween 0.5% and 4% of the world population, characterized by distinct 
acromic macules of various shapes and sizes, and may appear in any 
region of the skin. Worldwide, there are few publications on vitiligo 
that address epidemiological characteristics. Thus, the objective was to 
describe the clinical and epidemiological profile of patients with this 
condition at the State University of Pará’s Dermatology Clinic, in the 
city of Belém, Northern of Brazil. 
Methods and Findings: A cross-sectional descriptive study was 
performed, in which 180 medical records of patients treated at the 
State University of Pará’s Dermatology Clinic, from July 2000 to July 
2014, were analyzed using a protocol consisting of variables related 
to the disease. The information obtained was organized in a data-
base and submitted to descriptive and inferential statistical analysis. 
The study was approved by the ethics and research committee under 
the number 923.213. A predominance of the female gender (72.2%) 
and of the adult age group (55%) was observed; vitiligo without 
relation to family history (46.7%); without progression (58.3%); with 
a predominant clinical form of the generalized type (67.2%), being 
the common generalized one with the highest prevalence (57%). 
The most affected sites were head and neck (27.5%), and upper 
limbs (25.3%). 
Conclusions: This study revealed the characteristics of the vitiligo 
patients residing in the Amazon region, in which most patients had 
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Introduction
Vitiligo is the most common acquired hypomelano-
sis described in literature. This disease affects bet-
ween 0.5 and 4% of the world population, with no 
distinction of gender, age or ethnicity for its deve-
lopment. It is characterized by white patches, with 
sharp margins, of varying shapes and sizes and a 
trend of centrifugal development, which can arise 
in any region of the integument. As most patients 
develop the disease early in adulthood, vitiligo ulti-
mately influences the personal, psychological, and 
professional development of the individual. A sig-
nificant number of patients present symptoms of 
depression and anxiety, and may also negatively 
influence their social life, leading to isolation [1, 2, 
3, 4].
Vitiligo is a dermatosis that can be identified by 
white patches, initially hypochromic (with little pig-
mentation), which are usually noticed in areas with 
greater sun exposure, such as the face, elbow, back 
of the hands and around body orifices. White spots 
are most commonly seen on the extremities (hands 
and feet), areas of extension and flexion (knees and 
elbows), on the head and genitals. Toes, hands and 
face are often the first ones affected [2, 3, 5].
This disease can be classified as localized and ge-
neralized. The localized form is composed of two 
types: focal, which is characterized by the presence 
of acromic maculae in a given area, without speci-
fic distribution; and segmental, characterized by the 
presence of macules covering a unilateral segment 
of the body, which may follow the distribution of a 
dermatome. The generalized form has three types: 
acrofacial, with the presence of distal lesions on the 
extremities and on the face; vulgar, characterized 
by acromic patches that have a variable distribu-
tion; and mixed, in which the two or more types 
combine [6].
The pigmentary alteration that occurs in vitiligo 
happens due to melanocyte impairment and some 
theories may clarify the origin of this disease. The 
most acceptable hypothesis is that it is autoim-
mune, because the melanocytes are destroyed se-
condary to the presence of autoantibodies. This 
theory is corroborated by the similarity with other 
autoimmune diseases such as pernicious anemia, 
Addison's disease, scleroderma, thyroiditis, among 
others [2, 6, 7].
Among the most frequent environmental trigger 
factors are: nutritional deficiency, emotional stress, 
physical trauma (Köebner's phenomenon), drugs, 
infections, exposure to sun and chemicals, sepsis 
and toxins, among others [8, 6].
Vitiligo does not cause symptoms in other sys-
tems, and does not threaten the individual's phy-
sical health. However, due to the presence of the 
maculae, vitiligo patients may develop personality 
changes, low self-esteem and stress, also there are 
reports of interference with sexual relations due to 
embarrassment [7, 9].
Empirical data demonstrate that the esthetic 
problem is often more significant than the disease 
itself, thereby causing greater emotional and social 
the generalized clinical form, achieved improvement of the lesions 
with the proposed treatment, and only a minority presented progres-
sion of the disease. It is concluded that vitiligo is a disease with great 
therapeutic difficulty, and it is emphasized the importance of an early 
diagnosis, since in the early stages is easier to resolve the disease.
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suffering on the patients. Therefore, these patients’ 
life quality becomes compromised, requiring health 
professionals to intervene with a focus on these 
factors [10].
Vitiligo’s treatment is necessary when the patient 
suffers socially and/or emotionally. There are many 
options available, many of them aimed at restoring 
skin color; among them, we can mention the cor-
ticosteroid ointments and the photochemotherapy 
with psoralen drugs. The treatment choice takes 
into account the extent of hypochromia, the skin 
tone, and the psychological state of the patient. 
Thus, the treatment generally contributes to the sig-
nificant improvement of the patient's self-esteem 
and life quality [7, 9].
Currently, in the Brazilian literature, there is a 
shortage of papers that demonstrate the clinical and 
epidemiological profile of this dermatosis. Thus, this 
work aimed to describe this profile with the purpose 
of showing how this disease behaves in an Ama-
zonian population and also to stimulate physicians 
to fully evaluate patients with vitiligo, in addition 
to early identification of patients with this disease, 
accelerating the onset of treatment and thus reduce 
the negative psychosocial impacts of this disease 
and, consequently, its morbidity.
Materials and Methods
This is a retrospective, descriptive, cross-sectional 
study on the clinical and epidemiological profile of 
patients with vitiligo treated at the Dermatology 
Clinic of the State University of Pará, located in the 
city of Belém, Brazil. Data was collected through 
medical records.
The research was carried out in accordance with 
the provisions of the Declaration of Helsinki and the 
Nuremberg Code, in compliance with the National 
Health Council's Research Guidelines Involving Hu-
man Beings of Brazil (Res. CNS 466/12), with the 
approval of the research project by the Ethics Co-
mitee of the State University of Pará – UEPA – Cen-
ter for Biological and Health Sciences (Opinion No. 
923.213, approved on December 19, 2014), autho-
rization by the research director and the director of 
the Dermatology Clinic of the State University of 
Pará (UEPA).
In this study, the medical records of patients with 
vitiligo treated at the UEPA’s Dermatology Clinic 
were included between July 2000 and July 2014, 
with no age limits, race, marital status, social class, 
education or religion. Medical records of patients 
seen outside this period and incomplete, illegible 
and/or damaged were excluded from the study.
The sample consisted initially of 217 patients’ 
diagnosed with vitiligo medical records, of which 
37 were excluded, statistically and qualitatively jus-
tified, leaving the final sample established at 180 
medical records. To perform the present study from 
a target population (total number of records) of N 
= 217 patients with vitiligo, a random sampling 
without replacement was performed. By the appli-
cation of the sampling technique, the sample error 
was previously set at 5%. The application of the 
formula n = N / (1+ (N-1) * Error ^ 2) resulted in 
the sample size n = 180.
For the data collection a protocol was used, and 
it consisted of patient’s gender and age; age of le-
sions onset and initiation of treatment; presence of 
family history; skin color; lesions classification, type 
(localized or generalized); if classified as localized, 
the subtype (focal or segmental); if it was of the 
generalized type, the subtype (acrofacial, vulgar 
or mixed); location (head and neck, trunk, upper 
limbs, lower limbs or mucous membranes); related 
triggering factor (stress, physical trauma, none or 
uninformed); disease activity (with or without pro-
gression); regular monitoring; improvement with 
treatment and maintenance of treatment.
To identify the main factors in a sample of 180 
patients with vitiligo, descriptive and inferential sta-
tistical methods were applied. Quantitative variables 
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were presented by measures of central tendency 
and variation. The qualitative variables were presen-
ted by absolute and relative frequency distributions. 
The qualitative variables were compared using the 
Chi-square test, and when the npq < 5 constra-
int occurred then the G test [11] was applied. The 
comparison between the quantitative variables was 
performed by T Student test. The significance le-
vel alpha = 0.05 was previously set for rejection of 
the null hypothesis. Statistical processing was per-
formed using software GrafTable version 2.0 and 
BioEstat version 5.3.
Results
One hundred and eighty (180) patients with vitiligo 
were studied during the research period. There was 
a predominance of the female gender (72.2%), abs-
ence of a family history of vitiligo (46.7%), affecting 
mostly the adult age group (55%), with 57.2% of 
disease onset in children and 72.8% of uninformed 
skin color. The patients' age range was from 3 to 
84 years old, with a central tendency to 31.9 years 
old and a standard deviation of 19.5 years old. They 
were divided by age groups: children (0 to 19 years 
old), adults (20 to 59 years old) and elderly (above 
60 years old). As for the skin color, among the re-
cords in which the information was reported, there 
was a predominance of the brown color (23.9%) 
(Table 1).
As for the vitiligo type, the most noticeable was 
the generalized type (67.2%), followed by the vul-
gar subtype (57%), with head and neck location 
(27.5%), uninformed triggering factor (58.3%), in 
patients with regular follow-up (74.4%), who im-
proved with treatment (77.8%) and maintained out-
patient treatment (60%), as shown in Table 2.
When comparing the male and female genders, 
there was no statistically significant difference bet-
ween them in the vitiligo age of onset, the type 
of vitiligo more frequent and the triggering factor 
(Figure 1).
Table 1.  Characterization of patients with vitiligo, 
treated at a Dermatology Service in Belém/
PA, Brazil, between 2000 and 2014.
Characterization N  % p-value
Gender  
Male 50 27.8
 <0.0001*
Female 130 72.2
Family history   
Yes 35 19.4
 <0.0001*No 84 46.7
Non informed 61 33.9
Age group   
Children 62 34.4
 <0.0001*Adults 99 55.0
Elderly 19 10.6
Age of disease onset   
Children 103 57.2
 <0.0001*Adults 67 37.2
Elderly 10 5.6
Skin color   
White 3 1.7
 <0.0001*
Brown 43 23.9
Black 3 1.7
Non informed 131 72.8
*: Chi-square of adhesion
Table 2.  Characterization of vitiligo type of patients 
treated at a Dermatology Service in Belém/
PA, Brazil, between 2000 and 2014.
Characterization n  % p-value
Type of vitiligo   
Localized 59 32.8
 <0.0001*
Generalized 121 67.2
Localized type (n=59)   
Focal 51 86.4
 <0.0001*
Segmental 8 13.6
Generalized type (n=121)
Acrofacial 16 13.2
 <0.0001*Vulgar 69 57.0
Mixed 36 29.8
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Characterization n  % p-value
Localization   
Head and neck 100 27.5
 <0.0001*
Upper limbs 92 25.3
Trunk 69 19.0
Lower limbs 85 23.4
Mucosae 17 4.7
Triggering factor   
Emotional stress 36 20.0
 0.3135
Fisical trauma 27 15.0
None 24 13.3
Non informed 93 51.7
Activity (Progression)   
With progression 75 41.7
 <0.0001*
Without progression 105 58.3
Performs regular monitoring?
Yes 134 74.4
 <0.0001*
No 46 25.6
Had improvement with treatment? 
Yes 140 77.8
 <0.0001*
No 40 22.2
Maintains treatment?   
Yes 108 60.0
 <0.0001*
No 72 40.0
*: Chi-square of adhesion
Figure 1: Vitiligo age of onset, type of vitiligo and 
presence of triggering factor according 
to the gender of patients with vitiligo 
treated at a Dermatology Service in Be-
lém/PA, Brazil, from 2000 to 2014 (p-va-
lue> 0.5, Chi-square of independence).
Figure 2:  Vitiligo type according to age group of 
patients treated at a Dermatology Ser-
vice in Belém/PA, Brazil, from 2000 to 
2014 (p-value> 0.5, Qui-square of inde-
pendence).
Figure 3:  Disease progression according to the 
age range of patients with vitiligo, trea-
ted at a Dermatology Service in Belém/
PA, Brazil, from 2000 to 2014 (p-value> 
0.05, Qui-square of independence).
Regarding the types of generalized and localized 
vitiligo, there was no statistically significant diffe-
rence between them when compared in the age 
groups (Figure 2).
As for the progression of vitiligo, there was no 
statistically significant difference in any of the age 
groups (Figure 3).
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Discussion
Regarding the epidemiological characterization of 
the patients there was predominance of females. 
Similar results have been found in other studies [6, 
12, 13, 14], although some authors claim that viti-
ligo affects both sexes equally [4, 15]. It is inferred 
that the female sex tends to seek health services 
more, and particularly in cases of vitiligo, there is 
a greater aesthetic concern and social impact for 
women [12, 14].
In the present study, there was a predominance 
of the disease in the adults, from 20 to 59 years 
old, in agreement with studies performed in Brazil 
[6, 12], Cuba [16] and Turkey [17]. A study carried 
out in India found out that vitiligo is more common 
in the age group from 2 to 20 years old [18]. These 
divergences in the literature indicate that vitiligo can 
occur at any age, although it tends to affect young 
individuals.
The onset of vitiligo can occur at any age, but 
usually happens in childhood or in young adults. 
The onset peak is between 10 and 30 years old, 
with 50% of cases appearing before the second de-
cade of life [19, 20, 21]. The results of this study are 
in agreement with these data when demonstrates 
that vitiligo began predominantly in the age group 
that included individuals from 0 to 19 years. Among 
the various theories that explain the onset of the 
disease, it is proposed that vitiligo is a multifactorial 
cause pathology, with genetic and environmental 
factors involved in its onset. Therefore, the same 
causal mechanism may not apply to all patients and 
different pathophysiological pathways may conver-
ge together for the same clinical manifestation [22].
Approximately 20% of vitiligo patients have a 
family history of the disease in at least one first-
degree relative [21]. Vitiligo is a polygenic or multi-
factorial disease. Genetically, it has been associated 
with more than a dozen genes, which plays a role 
in different immunity changes in the pigment loss 
process [23]. Similar to the present study, Reghu et 
al. [18] found that 18.8% of those affected by the 
disease had a family history of vitiligo. In a hospital 
in Santa Catarina, south of Brazil, Nunes and Esser 
[6] observed that 10.6% of patients with vitiligo had 
a family history of dyschromia.
It was observed that in most of the charts of 
this survey there was no filling of patients' skin co-
lor. However, the brown color was predominant, 
which corroborates the clinical and epidemiological 
analysis of vitiligo in childhood, carried out in Minas 
Gerais, Brazil, by Silva et al. [20]. Nunes and Esser [6] 
and Barros et al. [12] also noted that the majority of 
patients were of phototype IV, which corresponds 
to brown color. This fact probably reflects the cha-
racteristics of the skin color of the Brazilian popula-
tion and the patients seen at the University (UEPA) 
outpatient clinic (northern region of the country). In 
addition, there is more evidence of lesions in dark-
skinned people, although vitiligo affects people of 
all races [20].
The prevalence of generalized type vitiligo was 
found in this study, agreeing with the results found 
by other researchers and presenting statistical re-
levance. For Marinho et al. [2], in a series of 94 
children and 25 adolescents conducted in Rio de 
Janeiro, Brazil; and in the study by Sori et al. [24], 
which analyzed the most prevalent hypomelanoses 
in childhood in an Indian dermatology service with a 
population of 23 patients with vitiligo, the prevalent 
clinical form of the disease was also the generalized 
type. In a study carried out in Mexico, in a sample 
of 218 patients, the generalized clinical form was 
observed in 88% of the patients [25]. Nunes and 
Esser [6] and Barros et al. [12] also showed similar 
results in populations of all ages.
When analyzing separately the localized and ge-
neralized types of this dermatosis and its various 
forms of manifestations (subtypes), for the first type 
the predominance of localized vitiligo followed by 
the segmental agrees with Nunes and Esser [6], 
Santander [25] and Sori et al. [24]. For the generali-
zed type of the disease, the highest incidence of the 
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vulgar form was also observed by the same authors, 
followed by the acrofacial and mixed forms. Howe-
ver, the difficulty of comparison with other studies 
is highlighted due to the use of several classifica-
tions, low adherence and failure of the consensus 
suggested by The Vitiligo Global Issues Consensus 
Conference [1], being the present investigation per-
formed corresponding to the classification used in 
the consensus.
Thus, among the patients investigated, there was 
a greater occurrence of common generalized pre-
sentation of the disease. Taking into account the 
multifactorial and polygenic etiology of this disor-
der and the various factors that may be associated 
with the appearance of new lesions, such as phy-
sical trauma (Köebner's phenomenon), emotional 
stress and infections, this event may be related to 
the characteristic of the vulgar form of vitiligo (ran-
dom acoustic macules) to admit greater variability 
of presentations [4, 8].
The most common location of vitiligo in this stu-
dy was the head and neck, followed by the upper 
limbs, lower limbs, trunk, and mucosae. On one 
hand, the location mainly in the head and neck 
coincides with literature data [20, 26, 27]. Other 
studies have reported upper limbs as the most fre-
quent site [6, 17, 28]. On the other hand, the data 
found in the present study differ from those found 
by Schwartz and Janniger [29], who state that there 
is a predilection for orifices - eyes, nostrils, mouth, 
nipples, belly button and genitalia.
In this investigation, the presence of triggering 
factor - emotional stress and physical trauma - did 
not occur in a significantly different way. This corro-
borates with studies in which the triggered investi-
gators of emotional stress, physical trauma or none 
also did not have statistically significant importance 
[6, 12].
The data found disagreed with Reghu et al. [18] 
and Shah et al. [30], in which the major vitiligo 
precipitating factor was physical trauma/injury, 
compared to emotional disturbance. Whereas for 
Cavalcante et al. [31] the most prevalent triggering 
factor was emotional stress.
The aggravating factor found in this analysis is 
that the variables related to the triggering factor and 
skin color presented a large amount of individuals 
with no such information in the collected charts, 
which may have interfered in the results found re-
garding the statistical significance. This underscores 
the need for a more complete and descriptive com-
pletion of information related to the patient.
This study showed that most of the patients pre-
sented lesions without progression, which was co-
rroborated by some studies: one from Tunisia and 
three from Brazil. In the demonstration of Ben Ah-
med et al. [32], 66.6% had vitiligo in regression or 
stable, statistic similar to that found by Correia and 
Borloti. [33]; in the study by Nunes and Esser [6], 
it was observed that only 21.2% of the patients 
had the disease progressing and for Castro [34], a 
progression was observed in 27.3% of the cases. 
Oppositely, a more recent study by Barros et al. 
[12] at a dermatology institute in São Paulo showed 
unstable disease activity, that is, with progression in 
63.4% of the patients.
Based on the assumption that stopping disease 
progression is a prerequisite for successful repig-
mentation in the treatment of vitiligo, knowing the 
progression prevalence and origin is an important 
step in the treatment choice and the possible cure 
of this disease [35].
Studies that aimed to clarify the immunological 
component in the vitiligo pathophysiology points to 
specific CD8+ T lymphocytes against melanocytes, 
a capacity of destroying them in the individuals 
diagnosed with this disease, and those who have 
progressing disease also have this cells in greater 
numbers [36].
Another elucidation of this analysis was that the 
majority of patients performed regular follow-up 
at the dermatology service, and obtained improve-
ment with the treatment, consequently, maintained 
clinical therapeutics. These results are confirmed by 
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other studies. Marinho et al. [2] found a rate of 
84% of patients who maintained regular follow-up 
and treatment; for Correia and Borloti [33], 96.82% 
of the patients started medical follow-up, but of 
these, only 36% followed all the prescribed re-
commendations; drawing attention to the fact that 
77% of the patients studied had performed some 
treatment not recommended by doctors. In this stu-
dy it was observed that 49% of patients abandoned 
treatment. In contrast, in a South Korean study, the 
vast majority of patients (94.5%) did not improve 
with the proposed treatment [37].
In the present registry, it was observed that there 
was no statistically significant difference in the vitili-
go onset age between males and females. Marino 
et al [2] have shown that vitiligo appears later in 
men. However, it was noted that studies that es-
tablish these differences and observations are still 
scarce.
When comparing gender with the most frequent 
type of vitiligo, the generalized type predominated 
in the male and female genders, and there were no 
significant differences between the results found. 
Similar results were found in a study performed in 
Turkey by Gönül et al. [38], where the generalized 
type, especially the involvement of the trunk, was 
significantly higher in women, which can be explai-
ned by the Köebner phenomenon, since women 
wear tighter clothes and bras. In the same Turkish 
study, the generalized type also predominated in 
the male gender, but the genital involvement was 
significantly higher, which according to the authors 
may also be due to the Köebner phenomenon, but 
because of sexual activity.
The difference between genders and the trigge-
ring factor was not significant as well, which was 
in agreement with data from Gönül et al. [38], who 
investigated the association of vitiligo with triggers 
among men and women, such as depression, but 
found no significant statistical difference in the 
compared data.
When comparing the patients’ age with the cu-
rrent disease type, it was observed the generalized 
type predominance, taking into account the avera-
ge age as well as when the analysis according to 
the age groups was made separately. However, in 
none of the comparisons was there a statistically 
significant difference. These findings are in agre-
ement with other studies [22, 39, 40]. However, 
other authors point to the occurrence of 87% of 
vitiligo in individuals under 20 years old [23].
The present study showed that there was no di-
fference in the propensity for vitiligo progression 
among the age groups, contrasting with another 
registry in which children and adolescents were 
more likely to have stable vitiligo than adults and 
the elderly [12].
Out of the 217 patients' records with this condi-
tion in the dermatology service in question, 37 were 
not used because they were not in good conditions 
(illegible, incomplete or damaged). The importance 
of the proper filling and handling of this document 
by all professionals is emphasized in order to safe-
guard the information of the patient's medical his-
tory and to guarantee support and safety for medi-
cal practice in cases of contestations. When taking 
into account and interpreting the several variables 
that characterize clinically and epidemiologically the 
vitiligo patients, great differences and peculiarities 
are observed according to each population inves-
tigated, referring to the intrinsic aspects of the in-
vestigated individuals, such as gender, age group, 
etc. The understanding of the clinics of the vitiligo 
patients, both physically and psychically, is indispen-
sable for a better therapeutic behavior, using the 
greatest arsenal of knowledge about the factors 
related to etiopathogenesis, evolution and available 
treatment of this disease, in order to promote satis-
factory life quality to the patient. It also warns of the 
importance of similar studies in order to get a better 
understanding of the different characteristics of the 
users of dermatology services with the purpose of 
increase and benefit the results of the relationship 
between the binomial: doctor and patient.
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Conclusion
The characteristics of the vitiligo patients residing 
in the Amazon region were known and it was ob-
served that the patients predominantly presented 
the generalized clinical form, despite the follow-up 
in a specialized service; the majority of the patients 
obtained lesions improvement with the proposed 
treatment and only a minority presented progres-
sion of the disease. It is concluded that vitiligo is a 
disease with great therapeutic difficulty, and it is 
emphasized the importance of an early diagnosis, 
since this disease in the early stages is easier to 
solve.
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